Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers
Phase 1
Recruiting
- Conditions
- CancerSquamous Cell CarcinomaMerkel Cell CarcinomaNeoplasmsTriple Negative Breast CancerOvarian CancerBladder CancerGastric CancerUrothelial CarcinomaMetastatic Cancer
- Interventions
- First Posted Date
- 2020-02-07
- Last Posted Date
- 2025-07-20
- Lead Sponsor
- Ocellaris Pharma, Inc.
- Target Recruit Count
- 116
- Registration Number
- NCT04260802
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦Ottawa Hospital Cancer Centre (OHRI), Ottawa, Ontario, Canada
🇨🇦Princess Margaret Hospital, Toronto, Ontario, Canada
News
No news found